These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34738504)

  • 21. Virtual screening of dipeptidyl peptidase-4 inhibitors using quantitative structure-activity relationship-based artificial intelligence and molecular docking of hit compounds.
    Hermansyah O; Bustamam A; Yanuar A
    Comput Biol Chem; 2021 Dec; 95():107597. PubMed ID: 34800858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybrid docking-QSAR studies of DPP-IV inhibition activities of a series of aminomethyl-piperidones.
    Amini Z; Fatemi MH; Gharaghani S
    Comput Biol Chem; 2016 Oct; 64():335-345. PubMed ID: 27570070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DPP-IV Inhibitory Phenanthridines: Ligand, Structure-Based Design and Synthesis.
    Khalaf RA; Masalha D; Sabbah D
    Curr Comput Aided Drug Des; 2020; 16(3):295-307. PubMed ID: 30526469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated Protocol to Design Potential Inhibitors of Dipeptidyl Peptidase- 4 (DPP-4).
    Pantaleão SQ; Philot EA; de Oliveira Almeida M; Lima AN; de Sairre MI; Scott AL; Honorio KM
    Curr Top Med Chem; 2020; 20(3):209-226. PubMed ID: 31878857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of triazole based uracil derivatives as novel DPP-4 inhibitors.
    Li Q; Han L; Zhang B; Zhou J; Zhang H
    Org Biomol Chem; 2016 Oct; 14(40):9598-9611. PubMed ID: 27714283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
    Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Click inspired novel pyrazole-triazole-persulfonimide & pyrazole-triazole-aryl derivatives; Design, synthesis, DPP-4 inhibitor with potential anti-diabetic agents.
    Nidhar M; Khanam S; Sonker P; Gupta P; Mahapatra A; Patil S; Yadav BK; Singh RK; Kumar Tewari A
    Bioorg Chem; 2022 Mar; 120():105586. PubMed ID: 35051706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D QSAR and docking studies of various amido and benzyl-substituted 3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl analogs as DPP-IV inhibitors.
    Agrawal R; Jain P; Dikshit SN; Jain S
    Protein Pept Lett; 2013 Sep; 20(9):1066-78. PubMed ID: 23607811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies.
    Cabezas D; Mellado G; Espinoza N; Gárate JA; Morales C; Castro-Alvarez A; Matos MJ; Mellado M; Mella J
    J Biomol Struct Dyn; 2023; 41(22):13250-13259. PubMed ID: 36718094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.
    Patel PD; Patel MR; Kaushik-Basu N; Talele TT
    J Chem Inf Model; 2008 Jan; 48(1):42-55. PubMed ID: 18076152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening.
    Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S
    J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-glycemic potential of benzophenone thio/semicarbazone derivatives: synthesis, enzyme inhibition and ligand docking studies.
    Arshia ; Fayyaz S; Shaikh M; Khan KM; Choudhary MI
    J Biomol Struct Dyn; 2022 Oct; 40(16):7339-7350. PubMed ID: 33769204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragment-based QSAR study to explore the structural requirements of DPP-4 inhibitors: a stepping stone towards better type 2 diabetes mellitus management.
    Dey PK; Dutta R; Ray M; Jakkula P; Banerjee S; Qureshi IA; Gayen S; Amin SA
    SAR QSAR Environ Res; 2024 Jun; 35(6):483-504. PubMed ID: 38904353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3D-QSAR modeling and molecular docking studies on a series of 2, 4, 5-trisubstituted imidazole derivatives as CK2 inhibitors.
    Goudzal A; El Aissouq A; El Hamdani H; Hadaji EG; Ouammou A; Bouachrine M
    J Biomol Struct Dyn; 2023 Jan; 41(1):234-248. PubMed ID: 35068344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3D-QSAR studies on fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors by CoMFA and CoMSIA.
    Zeng J; Liu G; Tang Y; Jiang H
    J Mol Model; 2007 Sep; 13(9):993-1000. PubMed ID: 17618469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, in vitro evaluation, and computational simulations studies of 1,2,3-triazole analogues as DPP-4 inhibitors.
    Vo DV; Hong KH; Lee J; Park H
    Bioorg Med Chem; 2021 Jan; 29():115861. PubMed ID: 33214038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
    Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular docking studies and 2D analyses of DPP-4 inhibitors as candidates in the treatment of diabetes.
    Pantaleão SQ; Maltarollo VG; Araujo SC; Gertrudes JC; Honorio KM
    Mol Biosyst; 2015 Nov; 11(11):3188-93. PubMed ID: 26399297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural modification of 4, 5-dihydro-[1, 2, 4] triazolo [4, 3-f] pteridine derivatives as BRD4 inhibitors using 2D/3D-QSAR and molecular docking analysis.
    Tong JB; Luo D; Feng Y; Bian S; Zhang X; Wang TH
    Mol Divers; 2021 Aug; 25(3):1855-1872. PubMed ID: 33392965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment.
    Pissurlenkar RR; Shaikh MS; Coutinho EC
    J Mol Model; 2007 Oct; 13(10):1047-71. PubMed ID: 17676345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.